DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26

Biochem Biophys Res Commun. 1991 Apr 30;176(2):690-7. doi: 10.1016/s0006-291x(05)80239-6.

Abstract

A type II DNA topoisomerase has been partially purified from calf thymus mitochondria by a combination of differential centrifugation and column chromatography. The mitochondrial enzyme was inhibited by amsacrine (m-AMSA) slightly at 0.5 microM, significantly at 5.0 microM, and completely at 50 microM. A similar profile was obtained with teniposide (VM-26) although the latter drug was not quite as potent an inhibitor as the former. P4 unknotting assays of the purified nuclear type II topoisomerase in the presence of m-AMSA and VM-26 indicated that the mitochondrial and nuclear enzymes behaved similarly, although the mitochondrial enzyme appeared to be inhibited more strongly.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amsacrine / pharmacology*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cattle
  • Centrifugation
  • Chromatography
  • DNA-Directed DNA Polymerase / metabolism
  • Mitochondria / drug effects
  • Mitochondria / enzymology*
  • Teniposide / pharmacology*
  • Thymus Gland / enzymology
  • Topoisomerase II Inhibitors*

Substances

  • Antineoplastic Agents
  • Topoisomerase II Inhibitors
  • Amsacrine
  • Teniposide
  • DNA-Directed DNA Polymerase